Literature DB >> 12191613

Structure, activity, regulation, and inhibitor discovery for a protein kinase associated with apoptosis and neuronal death.

Anastasia V Velentza1, Andrew M Schumacher, D Martin Watterson.   

Abstract

Death-associated protein kinase (DAPK) is a calmodulin-regulated serine/threonine protein kinase associated with neuronal cell death in animal models of disease. The recent determination of the 1.5A crystal structure of the catalytic kinase domain of DAPK, the discovery of amino acid sequence motifs with sites that are preferentially phosphorylated by this kinase, and the development of a quantitative enzyme activity assay provide a firm foundation for future studies into its regulation, the identification of its physiological substrates, and discovery of inhibitors. We summarize the relevant background and ongoing investigations that will increase our understanding of the role and regulation of this prototype death-associated kinase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12191613     DOI: 10.1016/s0163-7258(02)00190-0

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  4 in total

1.  Fluorescence linked enzyme chemoproteomic strategy for discovery of a potent and selective DAPK1 and ZIPK inhibitor.

Authors:  David A Carlson; Aaron S Franke; Douglas H Weitzel; Brittany L Speer; Philip F Hughes; Laura Hagerty; Christopher N Fortner; James M Veal; Thomas E Barta; Bartosz J Zieba; Avril V Somlyo; Cindy Sutherland; Jing Ti Deng; Michael P Walsh; Justin A MacDonald; Timothy A J Haystead
Journal:  ACS Chem Biol       Date:  2013-10-17       Impact factor: 5.100

2.  Protein kinase involved in lung injury susceptibility: evidence from enzyme isoform genetic knockout and in vivo inhibitor treatment.

Authors:  Mark S Wainwright; Janet Rossi; James Schavocky; Susan Crawford; David Steinhorn; Anastasia V Velentza; Magdalena Zasadzki; Vladimir Shirinsky; Yuzhi Jia; Jacques Haiech; Linda J Van Eldik; D Martin Watterson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-02       Impact factor: 11.205

3.  Discovery of a new class of synthetic protein kinase inhibitors that suppress selective aspects of glial activation and protect against beta-amyloid induced injury: a foundation for future medicinal chemistry efforts focused on targeting Alzheimer's disease progression.

Authors:  D Martin Watterson; Anastasia V Velentza; Magdalena Zasadzki; Jeffrey M Craft; Jacques Haiech; Linda J Van Eldik
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866

Review 4.  Death Associated Protein Kinase 1 (DAPK1): A Regulator of Apoptosis and Autophagy.

Authors:  Pratibha Singh; Palaniyandi Ravanan; Priti Talwar
Journal:  Front Mol Neurosci       Date:  2016-06-23       Impact factor: 5.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.